Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab

NCT03688178 is registered in ClinicalTrials.gov with Annick Desjardins, MD as lead sponsor.

NCT NCT03688178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03688178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
Lead sponsor
Annick Desjardins, MD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 26, 2020
Completion date
March 31, 2027
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma